In the acetic-acid-induced colitis model, dulaglutide enhanced intestinal barrier function, upregulating colonic Trefoil Factor (TFF)-3 expression, as measured by enzyme-linked immunosorbent assay (ELISA) [21]. The gene discussed is TFF3; the disease is colitis.